WebApr 11, 2024 · StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report report published on Monday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Brooklyn ImmunoTherapeutics stock opened at $3.38 on Monday. … WebEarnings; Newsletters; Trending. More. 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. BTX.X Bitcore. 266 ... Watchers 266 52-Wk Low $0.00 52-Wk High $0.00. Sentiment 0.00%. Message Vol. 14.29%. Latest BTX.X News. View. 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. Join the ...
BTX: NA - Detailed Earnings Estimates - Zacks.com
WebMay 10, 2024 · Market analysts’ prospects for this coming year seems pessimistic, with earnings becoming even more negative, reaching -US$35.76M in 2024. In the following year, earnings are predicted to hover... WebFind the latest Revenue & EPS data for Brooklyn ImmunoTherapeutics, Inc. Common Stock (BTX) at Nasdaq.com. Brooklyn ImmunoTherapeutics, Inc. Common Stock (BTX) … tarisa ams
Eterna Therapeutics Inc. (ERNA) Earnings Transcripts
WebMar 14, 2024 · CIK: 876343 Ticker: BTX Sentiment Sections Exhibits Stats Rating Learn More Filter Sentiment: All Positive Negative Filter Category: All Revenue Financial M & A Legal Other Filter Subcategory: All Product Expense Shares Other Inside Biotime Inc's 10-K Annual Report: Revenue - Product Highlight WebBTX Earnings Date Earnings announcement* for BTX: Sep 19, 2024 Brooklyn ImmunoTherapeutics, Inc. is estimated to report earnings on 09/19/2024. The upcoming … WebIn fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according ... 香水 使用期限 ジョーマローン